|
|
|
Corporate Profile: SciClone
Pharmaceuticals
| Summary: |
SciClone
has focused their current product development and
commercial activities on the following diseases:
hepatitis C, hepatitis B, hepatocellular carcinoma,
malignant melanoma, HIV, the virus that causes AIDS,
drug-resistant tuberculosis, and cystic fibrosis. |
| Address (HQ):
|
950 Tower Lane
Suite 900
Foster City, CA 94404-2125 |
| Phone #'s (HQ): |
Main |
(650) 358-3456 |
| Human Resources |
(650) 358-3456 |
| Investor Relations |
(650) 358-3457 |
| Fax #'s (HQ): |
Main |
(650) 358-3469 |
| Human Resources |
(650) 358-3469 |
| Investor Relations |
(650) 358-3469 |
| Financial
information: |
| SCLN |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
